Literature DB >> 11786731

Telomerase activity and expression of telomerase RNA component and catalytic subunits in precancerous and cancerous colorectal lesions.

Y Naito1, T Takagi, O Handa, T Ishikawa, N Matsumoto, N Yoshida, H Kato, T Ando, T Takemura, K Itani, H Hisatomi, Y Tsuchihashi, T Yoshikawa.   

Abstract

To investigate the role of telomerase activity in colorectal adenoma-carcinomas, telomerase activity, human telomerase RNA component (hTERC) and human telomerase reverse transcriptase (hTERT) mRNA were quantitatively analyzed in human cancerous and precancerous colorectal tissues. Sixty-six colorectal tumor specimens, including 10 invasive carcinomas, 6 mucosal carcinomas and 50 adenomas were evaluated. Ten specimens of normal tissue were also included in the study. Telomerase activity was assayed by semiquantitative fluorescence using the TRAP-eze(TM) telomerase detection kit. Analysis of the expression of each telomerase subunit gene was performed by real-time PCR amplification. There was a positive correlation between histological atypia and telomerase activity (rho = 0.700, p < 0.0001), hTERT mRNA expression (rho = 0.603, p < 0.0001), and hTERC expression (rho = 0.290, p < 0.05). There was also a positive correlation between the levels of hTERT mRNA and telomerase activity (r = 0.455, p < 0.01). Significant differences in the levels of hTERT mRNA were shown between normal tissues and the adenomas (p < 0.05) and between the mucosal carcinomas and invasive carcinomas (p < 0.05). The values of hTERC expression in neoplastic tissues were significantly higher than in the normal tissues; however, there were no significant differences between the adenomas and the carcinomas. In summary, although upregulation of hTERC expression is an early event in adenoma development, hTERT mRNA expression is gradually upregulated during the adenoma-carcinoma sequence and may be a rate-limiting determinant of telomerase activity. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11786731     DOI: 10.1159/000050640

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  6 in total

Review 1.  Telomeres, telomerase and colorectal cancer.

Authors:  Roberta Bertorelle; Enrica Rampazzo; Salvatore Pucciarelli; Donato Nitti; Anita De Rossi
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

2.  Functions and regulation of MUC13 mucin in colon cancer cells.

Authors:  Brij K Gupta; Diane M Maher; Mara C Ebeling; Phillip D Stephenson; Susan E Puumala; Michael R Koch; Hiroyuki Aburatani; Meena Jaggi; Subhash C Chauhan
Journal:  J Gastroenterol       Date:  2013-10-07       Impact factor: 7.527

3.  Telomerase activity in chronic inflammatory bowel disease.

Authors:  Elke Kleideiter; Ulrike Friedrich; Alexandra Möhring; Siegfried Walker; Emil Höring; Karlernst Maier; Peter Fritz; Klaus-Peter Thon; Ulrich Klotz
Journal:  Dig Dis Sci       Date:  2003-12       Impact factor: 3.199

4.  Telomerase detection in the diagnosis and prognosis of cancer.

Authors:  Eiso Hiyama; Keiko Hiyama
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

5.  High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma.

Authors:  E Hiyama; H Yamaoka; T Matsunaga; Y Hayashi; H Ando; S Suita; H Horie; M Kaneko; F Sasaki; K Hashizume; A Nakagawara; N Ohnuma; T Yokoyama
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

Review 6.  Variations in telomere maintenance and the role of telomerase inhibition in gastrointestinal cancer.

Authors:  Steffen Heeg
Journal:  Pharmgenomics Pers Med       Date:  2015-12-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.